BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4811225)

  • 1. Ergot alkaloids. Ergolines and related compounds as inhibitors of prolactin release.
    Cassady JM; Li GS; Spitzner EB; Floss HG; Clemens JA
    J Med Chem; 1974 Mar; 17(3):300-7. PubMed ID: 4811225
    [No Abstract]   [Full Text] [Related]  

  • 2. Ergot alkaloids. Synthesis of 6-alkyl-8-ergolenes and 6-methyl-8-aminoergolines as potential prolactin inhibitors.
    Crider AM; Robinson JM; Floss HG; Cassady JM; Clemens JA
    J Med Chem; 1977 Nov; 20(11):1473-7. PubMed ID: 915908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ergot alkaloids. Synthesis of 6-methyl-8-ergolenes as inhibitors of prolactin release.
    Li GS; Robinson JM; Floss HG; Cassady JM
    J Med Chem; 1975 Sep; 18(9):892-5. PubMed ID: 1159711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ergoline congeners as potential inhibitors of prolactin release. 2.
    Rusterholz DB; Barfknecht CF; Clemens JA
    J Med Chem; 1976 Jan; 19(1):99-102. PubMed ID: 1246056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of prolactin secretion by ergolines.
    Clemens JA; Shaar CJ; Smalstig EB; Bach NJ; Kornfeld EC
    Endocrinology; 1974 Apr; 94(4):1171-6. PubMed ID: 4818776
    [No Abstract]   [Full Text] [Related]  

  • 6. Reduction of serum prolactin in rats by 2 ergot alkaloids and 2 ergoline derivatives: a comparison.
    Brooks CL; Welsch CW
    Proc Soc Exp Biol Med; 1974 Jul; 146(3):863-7. PubMed ID: 4841203
    [No Abstract]   [Full Text] [Related]  

  • 7. Ergot alkaloids. New ergolines as selective dopaminergic stimulants.
    Stütz PL; Stadler PA; Vigouret JM; Jaton A
    J Med Chem; 1978 Aug; 21(8):754-7. PubMed ID: 567695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ergot alkaloids. Synthesis of nitrosourea derivatives of ergolines as potential anticancer agents.
    Crider AM; Lu CK; Floss HG; Cassady JM; Clemens JA
    J Med Chem; 1979 Jan; 22(1):32-5. PubMed ID: 423180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of D-oxa tricyclic partial ergolines as dopamine agonists.
    Booher RN; Kornfeld EC; Smalstig EB; Clemens JA
    J Med Chem; 1987 Mar; 30(3):580-3. PubMed ID: 3102743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive ergoline derivatives.
    Mantegani S; Temperilli A; Traquandi G; Salvati P; Di Salle E; Lamberti E; Bonsignori A
    Drug Des Deliv; 1987 May; 1(4):313-23. PubMed ID: 3509340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of prolactin by ergoline congeners.
    Barfknecht CF; Rusterholz DB
    J Med Chem; 1974 Mar; 17(3):308-12. PubMed ID: 4811226
    [No Abstract]   [Full Text] [Related]  

  • 12. [Synthesis of glycosides and sugar orthoesters of 9,10-dihydrolysergol].
    Seifert K; Johne S
    Arch Pharm (Weinheim); 1984 Jul; 317(7):577-83. PubMed ID: 6487053
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of the ergot derivative lisuride hydrogen maleate on serum prolactin concentrations in female rats.
    Gräf KJ; Neumann F; Horowski R
    Endocrinology; 1976 Mar; 98(3):598-605. PubMed ID: 1261489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Descarboxylysergic acid (9,10-didehydro-6-methylergoline).
    Bach NJ; Hall DA; Kornfeld EC
    J Med Chem; 1974 Mar; 17(3):312-4. PubMed ID: 4811227
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ergot alkaloids agroclavine-1 and epoxyagroclavine-1, metabolites of Penicillium corylophilum].
    Kozlovskiĭ AG; Solov'eva TF; Sakharovskiĭ VG; Adanin VM
    Prikl Biokhim Mikrobiol; 1982; 18(4):535-41. PubMed ID: 7122440
    [No Abstract]   [Full Text] [Related]  

  • 16. Mechanisms underlying the prolactin-lowering effect of meterogoline in the rat.
    Cocchi D; Locatelli V; Carminati R; Müller EE
    Life Sci; 1978 Sep; 23(9):927-36. PubMed ID: 703523
    [No Abstract]   [Full Text] [Related]  

  • 17. [Analogue drugs of ergot-alkaloids with an inhibitory effect upon prolactin secretion and their influence upon the mammary gland (author's transl)].
    Rezábek K; Ausková M; Semonský M
    Cesk Gynekol; 1975 Feb; 40(1):52-3. PubMed ID: 1131904
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of apomorphine hydrochloride, dibutyryl-apomorphine and Lysenyl on plasma prolactin concentrations in the rat.
    Horowski R; Neumann F; Gräf KJ
    J Pharm Pharmacol; 1975 Jul; 27(7):532-4. PubMed ID: 239161
    [No Abstract]   [Full Text] [Related]  

  • 19. Prolactin secretion inhibition by a new 8alpha-amino-ergoline, CH 29-171.
    Flückiger E; Briner U; Doepfner W; Kovacs E; Marbach P; Wagner HR
    Experientia; 1978 Oct; 34(10):1330-2. PubMed ID: 570121
    [No Abstract]   [Full Text] [Related]  

  • 20. A practical synthesis of cabergoline.
    Ashford SW; Henegar KE; Anderson AM; Wuts PG
    J Org Chem; 2002 Oct; 67(20):7147-50. PubMed ID: 12354014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.